Rehabilitation medicine is the fourth category of medicine that is juxtaposed with preventive medicine, clinical medicine, and health care medicine. It is an important part of the trinity of “prevention, clinical treatment, and rehabilitation” in modern medicine. With the advent of an aging society, rehabilitation medicine has become the fastest growing market in the medical industry.
Medical practice shows that rehabilitation medicine has obvious application value in general hospitals, such as fractures, craniocerebral injuries, cerebrovascular events, diabetes, cardiovascular diseases, rheumatoid arthritis, cervical spondylosis, waist and leg diseases, etc., intervention of rehabilitation medicine , More effectively accelerate the patient’s recovery process, improve the recovery effect, significantly reduce the rate of disability and lethality, and play a significant role in improving the overall clinical efficacy.
In recent years, the incidence of chronic diseases among our residents has continued to rise, especially hypertension, heart disease, diabetes, etc. According to the data from the Fifth National Health Service Survey, the prevalence of chronic diseases increases with age, the spectrum of diseases brought about by aging changes, the rehabilitation needs of the high-prevalence diseases of the elderly plus the needs caused by chronic disability , Will continue to expand the demand space of the rehabilitation medical industry. Since China’s rehabilitation medicine is still in the initial stage of development and has huge market potential, there is still substantial room for growth in the rehabilitation medicine industry.
Recently, the Industrial Securities Research Institute estimated that China ’s market size and growth rate in the next few years showed that in 2013, China ’s domestic rehabilitation medical market was only 20 billion yuan (15 yuan per capita), much lower than the US ’s 100 billion U.S. $ 80). If calculated according to the level that basically meets China’s rehabilitation needs, by 2023, the scale of China’s rehabilitation medical industry is expected to reach 103.8 billion yuan, and the compound annual growth rate is expected to be no less than 18%.
Post time: May-21-2020